Antibodies pose a double threat to HIV

被引：0

作者：

Haigwood, Nancy L. ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Div Pathobiol & Immunol, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA

来源：

NATURE | 2018年 / 561卷 / 7724期

关键词：

TREATMENT INTERRUPTION; MONOCLONAL-ANTIBODIES; SHIV; VRC01; NEUTRALIZATION; INFECTION; MACAQUES; 3BNC117; VIREMIA; HUMANS;

D O I：

10.1038/d41586-018-06773-8

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Drug treatments for HIV infection require the long-term use of daily medication that can have toxic side effects. A pair of HIV-targeting antibodies might offer an alternative therapeutic approach.

引用

页码：468 / 470

页数：3

共 50 条

[41] Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens
Alba, Christopher
Malhotra, Shelly
Horsfall, Stephanie
Barnhart, Matthew E.
Bekker, Adrie
Chapman, Katerina
Cunningham, Coleen K.
Fast, Patricia E.
Fouda, Genevieve G.
Freedberg, Kenneth A.
Goga, Ameena
Ghazaryan, Lusine R.
Leroy, Valeriane
Mann, Carlyn
Mccluskey, Margaret M.
Mcfarland, Elizabeth J.
Muturi-Kioi, Vincent
Permar, Sallie R.
Shapiro, Roger
Sok, Devin
Stranix-Chibanda, Lynda
Weinstein, Milton C.
Ciaranello, Andrea L.
Dugdale, Caitlin M.
PLOS ONE, 2025, 20 (03):
[42] Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates
de Castro, Isabela Silva
Gorini, Giacomo
Mason, Rosemarie
Gorman, Jason
Bissa, Massimiliano
Rahman, Mohammad A.
Arakelyan, Anush
Kalisz, Irene
Whitney, Stephen
Becerra-Flores, Manuel
Ni, Eric
Peachman, Kristina
Trinh, Hung, V
Read, Michael
Liu, Mei-Hue
Van Ryk, Donald
Paquin-Proulx, Dominic
Shubin, Zhanna
Tuyishime, Marina
Peele, Jennifer
Ahmadi, Mohammed S.
Verardi, Raffaello
Hill, Juliane
Beddall, Margaret
Nguyen, Richard
Stamos, James D.
Fujikawa, Dai
Min, Susie
Schifanella, Luca
Vaccari, Monica
Galli, Veronica
Doster, Melvin N.
Liyanage, Namal P. M.
Sarkis, Sarkis
Caccuri, Francesca
LaBranche, Celia
Montefiori, David C.
Tomaras, Georgia D.
Shen, Xiaoying
Rosati, Margherita
Felber, Barbara K.
Pavlakis, George N.
Venzon, David J.
Magnanelli, William
Breed, Matthew
Kramer, Josh
Keele, Brandon F.
Eller, Michael A.
Cicala, Claudia
Arthos, James
ISCIENCE, 2021, 24 (02)
[43] Spectrum of HIV antibodies in vaccine and disease
Tomaras, Georgia D.
Montefiori, David C.
CURRENT OPINION IN HIV AND AIDS, 2014, 9 (03) : 207 - 209
[44] Insights into neutralizing antibodies and HIV Envelope
Haigwood, Nancy L.
CURRENT OPINION IN HIV AND AIDS, 2006, 1 (04) : 301 - 308
[45] A role for antibodies in natural HIV control
Moris, Arnaud
Pereira, Mathias
Chakrabarti, Lisa
CURRENT OPINION IN HIV AND AIDS, 2019, 14 (04) : 265 - 272
[46] Inhibition of HIV protease by monoclonal antibodies
Rezacova, P
Brynda, J
Fabry, M
Horejsi, M
Stouracova, R
Lescar, J
Chitarra, V
Riottot, MM
Sedlacek, J
Bentley, GA
JOURNAL OF MOLECULAR RECOGNITION, 2002, 15 (05) : 272 - 276
[47] Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Stamatatos, Leonidas
Morris, Lynn
Burton, Dennis R.
Mascola, John R.
NATURE MEDICINE, 2009, 15 (08) : 866 - 870
[48] The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies
Peachman, Kristina K.
Wieczorek, Lindsay
Polonis, Victoria R.
Alving, Carl R.
Rao, Mangala
VIROLOGY, 2010, 408 (02) : 213 - 223
[49] HIV and Aging: Double Stigma
Brown, Monique J.
Adeagbo, Oluwafemi
CURRENT EPIDEMIOLOGY REPORTS, 2021, 8 (02) : 72 - 78
[50] A review of CCR5 antibodies against HIV: current and future aspects
Prathipati, Pavan Kumar
Mandal, Subhra
Destache, Christopher J.
THERAPEUTIC DELIVERY, 2019, 10 (02) : 107 - 112

← 1 2 3 4 5 →